4G Technology is driving the growth of Wearable Health Solutions, Inc. (OTCMKTS: WHSI) in the $166 billion mHealth Market. WHSI is readying for an up list by filing Form 10 and generating more capital with a fully subscribed $5 million Regulation ‘A’ offering.
The best is yet to come for this next-generation Company. In early 2022, WHSI plans to launch the iHelp MAX™4G in the personal medical alarms and safety alert devices market. It is already in the testing and production phase.
WHSI is marrying its ‘smart’ remote monitoring products with artificial intelligence (AI), Blue Tooth, Backend As A Service (Baas), IoT, Wi-Fi, Central Cloud Management and in 2022 4G telecommunications.
The key investment consideration for WHSI is a larger market share in several remote monitoring soaring markets employing the newest technology. WHSI is an innovator that participates in several dynamic markets:
• WHSI participates in the giant mobile health (mHealth) market which is forecast to reach $166.2 billion by 2028, according to GrandViewResearch. It sees this high technology industry growing at a 17.6% CAGR through 2028. New technologies and COVID-19 are driving this market for physicians and healthcare facilities.
• The $23.3 billion remote patient operating market (RPM). Research firm MarketsAndMarkets projects this market will grow at a CAGR of 38.2% to reach $117 billion by 2025. Body mounted sensors by WHSI transmit biological data for healthcare purposes. Chronic diseases and Telehealth drive this industry. GE Healthcare and Siemens AG are key players.
• WHSI is innovating in the $4 billion personal emergency response market. MarketDataForecast forecasts that the (PERS) market will grow from $4.09 billion in 2021 to $5.29 billion globally by the end of 2026. That represents CAGR growth of 5.3%.
Key is that WHSI is moving rapidly towards the telehealth market. It will offer physicians and medical facilities the medical vitals of a user. WHSI’s iHelp MAX™ 4G will be ‘telehealth ready’ when it launches early next year.
It will offer GPS tracking services plus remote patient monitoring (RPM). It will have body mounted sensors and artificial intelligence (AI). Fall detection and geofencing are other features. It features Wi-Fi, NFC (wireless data transfer) technology and Bluetooth 4.0 Low Energy features.
This sophisticated product will monitor and transmit to a network of monitoring stations through a subsidiary. WHSI is developing technology that can make its remote monitoring products even more sophisticated.
iHelp MAX™ 4G will offer two-way voice communication. And it will deliver data on a user’s vital health information. It will enable monitoring in the mobile health (mHealth) industry. A monitor will learn not only is the wearer in some distress, but have medical vitals to learn more.
Sales are made to healthcare facilities, including hospitals, home healthcare entities and direct to consumers. WHSI also sells through a global distribution network of independent dealers.
WHSI’s stock closed Friday at $0.0102, off 2.40%, in light volume of 3,473,781. YTD, WHSI’s stock is green.
In its newly filed Form 10 to the SEC, WHSI is forecasting volume of $5.87 million for the full year 2022. New telecommunications will be driving those sales. WHSI is marrying its proprietary technology with next generation products.
To make iHelp MAX™ 4G possible, WHSI has been aggressive in developing partnerships with technology companies:
- The Company has engaged R&D firm MIDI Product Development Corporation (MIDI), an expert in medical innovation. MIDI is to develop and commercialize for WHSI a biometric sensor to communicate with the company’s flagship product 4G iHelp MAX™ product platform. It is titled the iHelp Next Generation Platform (NGP).
WHSI-MIDI’s collaboration goal is to add to the platform’s existing safety monitoring capability. Health monitoring and medication reminders will be added. This next generation platform would monitor in real time medical vitals, such as blood pressure and oxygen levels.
• WHSI has acquired the assets and technology of mHealthCentral Cloud Management and Automation platform. The Baas technology dealer portal would be used in WHSI’s next generation iHelp™ MAX cellular and telehealth-ready mobile medical device.
• The Company has also signed a licensing agreement with Speak to IoT to bring its patent-pending voice technology enabling Voice AI control into all of the company’s existing Smart devices with IoT.
The result is that new voice technology will be embedded into WHSI’s 3G iHelp, 4G iHelp MAX and other Smart IoT products. Alexa, Google and other intelligent Voice Assistants would then offer hands-free voice command-and-control for WHSI devices.
Major companies are active in this global market. They include Philips Electronics, ADT Corporation and Alert One Services. They see growth in this space.
Technological vision is in WHSI’s favor. WHSI sees a fragmented market in which it can gain significant share against larger players.
Globe Small Cap Research LLC agrees. Globe’s analysis of WHSI’s plans to integrate voice AI technology into its Smart devices will differentiate WHSI products from competitors. At stake: this new technology broadens the target consumer market. It not only includes elderly and ill patients, but also the 200 million lone workers or employees who work alone.
Globe’s report also said WHSI would file a Form 10 in an uplift strategy. WHSI has already filed it. And to ensure the new technology is available, it recently fully subscribed its $5 million Regulation ‘A’ offering.
Keep WHSI on your watch list as it integrates technology into its increasingly sophisticated monitoring products. It competes in several dynamic growth markets. For more information, go to wearablehealthsolutions.com
This sponsored article is part of an investor education program.